Santermans E[au] - Search Results

Year	Number of Results
2013	1
2014	3
2015	5
2016	6
2017	4
2018	1
2019	3
2020	1
2021	2
2022	0

1

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects.

Timmis H, Van Kaem T, Desrivot J, Dupont S, Meuleners L, Beetens J, Helmer E, Santermans E, Huettner S. Timmis H, et al. Among authors: santermans e. Clin Pharmacol Drug Dev. 2021 Sep;10(9):994-1006. doi: 10.1002/cpdd.955. Epub 2021 May 7. Clin Pharmacol Drug Dev. 2021. PMID: 33960725 Free PMC article. Clinical Trial.

2

Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories.

Abrams S, Wambua J, Santermans E, Willem L, Kuylen E, Coletti P, Libin P, Faes C, Petrof O, Herzog SA, Beutels P, Hens N. Abrams S, et al. Among authors: santermans e. Epidemics. 2021 Jun;35:100449. doi: 10.1016/j.epidem.2021.100449. Epub 2021 Mar 23. Epidemics. 2021. PMID: 33799289 Free PMC article.

3

GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN).

van Koningsbruggen-Rietschel S, Conrath K, Fischer R, Sutharsan S, Kempa A, Gleiber W, Schwarz C, Hector A, Van Osselaer N, Pano A, Corveleyn S, Bwirire D, Santermans E, Muller K, Bellaire S, Van de Steen O. van Koningsbruggen-Rietschel S, et al. Among authors: santermans e. J Cyst Fibros. 2020 Mar;19(2):292-298. doi: 10.1016/j.jcf.2019.09.006. Epub 2019 Oct 5. J Cyst Fibros. 2020. PMID: 31594690 Free article. Clinical Trial.

4

Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design.

Santermans E, Ford P, Kreuter M, Verbruggen N, Meyvisch P, Wuyts WA, Brown KK, Lederer DJ, Byrne AJ, Molyneaux PL, Sivananthan A, Moor CC, Maher TM, Wijsenbeek M. Santermans E, et al. Adv Ther. 2019 Nov;36(11):3059-3070. doi: 10.1007/s12325-019-01093-3. Epub 2019 Sep 29. Adv Ther. 2019. PMID: 31565781 Free PMC article. Clinical Trial.

5

Household members do not contact each other at random: implications for infectious disease modelling.

Goeyvaerts N, Santermans E, Potter G, Torneri A, Van Kerckhove K, Willem L, Aerts M, Beutels P, Hens N. Goeyvaerts N, et al. Among authors: santermans e. Proc Biol Sci. 2018 Dec 19;285(1893):20182201. doi: 10.1098/rspb.2018.2201. Proc Biol Sci. 2018. PMID: 30963910 Free PMC article.

6

Overcoming the challenges of iris scanning to identify minors (1-4 years) in the real-world setting.

Masyn S, Vuchelen A, Santermans E, Rasschaert F, Bangura A, Parys W, Rutten R. Masyn S, et al. Among authors: santermans e. BMC Res Notes. 2019 Jul 22;12(1):448. doi: 10.1186/s13104-019-4485-8. BMC Res Notes. 2019. PMID: 31331369 Free PMC article.

7

Structural differences in mixing behavior informing the role of asymptomatic infection and testing symptom heritability.

Santermans E, Van Kerckhove K, Azmon A, John Edmunds W, Beutels P, Faes C, Hens N. Santermans E, et al. Math Biosci. 2017 Mar;285:43-54. doi: 10.1016/j.mbs.2016.12.004. Epub 2016 Dec 24. Math Biosci. 2017. PMID: 28027885

8

Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma.

Marcq E, Siozopoulou V, De Waele J, van Audenaerde J, Zwaenepoel K, Santermans E, Hens N, Pauwels P, van Meerbeeck JP, Smits EL. Marcq E, et al. Among authors: santermans e. Oncoimmunology. 2016 Nov 28;6(1):e1261241. doi: 10.1080/2162402X.2016.1261241. eCollection 2017. Oncoimmunology. 2016. PMID: 28197385 Free PMC article.

9

Interleukin-13 immune gene therapy prevents CNS inflammation and demyelination via alternative activation of microglia and macrophages.

Guglielmetti C, Le Blon D, Santermans E, Salas-Perdomo A, Daans J, De Vocht N, Shah D, Hoornaert C, Praet J, Peerlings J, Kara F, Bigot C, Mai Z, Goossens H, Hens N, Hendrix S, Verhoye M, Planas AM, Berneman Z, van der Linden A, Ponsaerts P. Guglielmetti C, et al. Among authors: santermans e. Glia. 2016 Dec;64(12):2181-2200. doi: 10.1002/glia.23053. Epub 2016 Sep 29. Glia. 2016. PMID: 27685637

10

Non-invasive PET imaging of brain inflammation at disease onset predicts spontaneous recurrent seizures and reflects comorbidities.

Bertoglio D, Verhaeghe J, Santermans E, Amhaoul H, Jonckers E, Wyffels L, Van Der Linden A, Hens N, Staelens S, Dedeurwaerdere S. Bertoglio D, et al. Among authors: santermans e. Brain Behav Immun. 2017 Mar;61:69-79. doi: 10.1016/j.bbi.2016.12.015. Epub 2016 Dec 23. Brain Behav Immun. 2017. PMID: 28017648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results